MedTrace Logo

Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial

NCT04801069 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-18

No results posted yet for this study

Summary

Sleep Apnea Syndrome (SAS) is highly prevalent in acute stroke and it is related to worst outcome. We aim to assess if SAS treatment, started immediately after acute ischemic stroke, impacts infarct growing and clinical prognosis.

Conditions

Interventions

DEVICE

Nocturnal Ventilation

AirCurve 10CS PaceWave (Resmed)

Sponsors & Collaborators

  • SOS Attaque Cérébrale

    lead OTHER

Principal Investigators

  • Elena Meseguer, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2023-03-15
Completion
2023-09-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04801069 on ClinicalTrials.gov